Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov;45(11):1284-92.
doi: 10.1038/ng.2792. Epub 2013 Oct 6.

Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome

Affiliations

Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome

Christopher J Lessard et al. Nat Genet. 2013 Nov.

Abstract

Sjögren's syndrome is a common autoimmune disease (affecting ∼0.7% of European Americans) that typically presents as keratoconjunctivitis sicca and xerostomia. Here we report results of a large-scale association study of Sjögren's syndrome. In addition to strong association within the human leukocyte antigen (HLA) region at 6p21 (Pmeta = 7.65 × 10(-114)), we establish associations with IRF5-TNPO3 (Pmeta = 2.73 × 10(-19)), STAT4 (Pmeta = 6.80 × 10(-15)), IL12A (Pmeta = 1.17 × 10(-10)), FAM167A-BLK (Pmeta = 4.97 × 10(-10)), DDX6-CXCR5 (Pmeta = 1.10 × 10(-8)) and TNIP1 (Pmeta = 3.30 × 10(-8)). We also observed suggestive associations (Pmeta < 5 × 10(-5)) with variants in 29 other regions, including TNFAIP3, PTTG1, PRDM1, DGKQ, FCGR2A, IRAK1BP1, ITSN2 and PHIP, among others. These results highlight the importance of genes that are involved in both innate and adaptive immunity in Sjögren's syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of genome-wide association results for 27,501 variants overlapping between DS1 and DS2 after imputation and meta-analysis. The −log10(P) for each variant is plotted according to chromosome and base pair position. A total of seven loci (in red font) exceeded the GWS of Pmeta < 5×10−8 (red dashed line). Suggestive threshold (Pmeta < 5×10−5) is indicated by a blue dashed line.
Figure 2
Figure 2
Zoomed in plots of the meta-analysis results for the seven regions with Pmeta<5×10−8. The HLA region (a) from Mb 28.4 to Mb 33.4 is shown for variants with Pmeta<5×10−8 only. Strong linkage disequilibrium (LD) was observed with variants extending from Class I through Class II (pairwise LD with rs115575857 is given in blue). A second independent effect was identified in Class II peaking at rs116232857 (pairwise LD is depicted in red). The red insert on the left shows a further zoomed in view of the top associated variants in the Class II region. (b) The area of association surrounding IRF5 is shown, including the pairwise LD with the top overall variant, rs3757387, in blue. Pairwise LD with the top SNP, rs17339836, in the second effect is shown in red. STAT4 (c), IL12A (d), BLK (e), CXCR5 (f) and TNIP1 (g) regions are also provided and include pairwise LD with the top listed variant shown in blue. The black dashed lines represent Pmeta = 5×10−8.
Figure 3
Figure 3
Identification of cis-eQTL in Sjögren’s syndrome-associated regions. Sjögren’s syndrome-associated variants in the HLA region within 100bp of RFX5 binding sites were evaluated for cis-eQTL with the expression of HLA genes in 222 European subjects. The top cis-eQTL in HLA-DRB6 (a), HLA-C (b), HLA-DPB1 (c), HLA-DQA1 (d), and HLA-A (e) are shown in the figure. We also identified cis-eQTL for top Sjögren’s syndrome-associated variants in IL12A (f), FAM167A-BLK (g, h), and TNIP1 (i). The risk genotype of each eQTL variant is plotted on the right side of each figure. Data are shown using box-and-whisker plots, in which distribution of the expression values are highlighted (median, upper quantile, lower quantile, maximum, and minimum). Each eQTL was evaluated using both a linear model and Analysis of Variance (ANOVA) model. Panel b only had one subject with the TT genotype; thus, we performed a t-test rather than an ANOVA to compare the TC to the CC genotype.

References

    1. Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15–25. - PubMed
    1. Pillemer SR, et al. Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001;76:593–9. - PubMed
    1. Plesivcnik Novljan M, et al. Incidence of primary Sjogren’s syndrome in Slovenia. Ann Rheum Dis. 2004;63:874–6. - PMC - PubMed
    1. Jonsson R, et al. The complexity of Sjogren’s syndrome: novel aspects on pathogenesis. Immunol Lett. 2011;141:1–9. - PubMed
    1. Vitali C, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding